Profile
Frédéric Legros currently works at ARTHEx Biotech SL, as Executive Chairman & Chief Executive Officer from 2023 and Anoat Therapeutics SAS, as Chairman from 2023.
Dr. Legros also formerly worked at BliNK Biomedical SAS, as Director, Valneva SE, as Vice President-Business Development from 2015 to 2017, Dynacure SA, as Chief Operating Officer from 2017 to 2022, and Cnrs Innovation SA, as Manager from 2003 to 2005.
Dr. Legros received his undergraduate degree from NEOMA Business School.
Frédéric Legros active positions
| Companies | Position | Start |
|---|---|---|
ARTHEx Biotech SL
ARTHEx Biotech SL Miscellaneous Commercial ServicesCommercial Services Engages in development of antisense RNA treatments against genetic diseases | Chief Executive Officer | 2023-05-02 |
Anoat Therapeutics SAS
Anoat Therapeutics SAS BiotechnologyHealth Technology Develops novel therapies for cystic fibrosis | Chairman | 2023-03-24 |
Former positions of Frédéric Legros
| Companies | Position | End |
|---|---|---|
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Chief Operating Officer | 2022-09-30 |
| VALNEVA SE | Corporate Officer/Principal | 2016-12-31 |
Cnrs Innovation SA
Cnrs Innovation SA Miscellaneous Commercial ServicesCommercial Services Provides scientific technology consulting services | Corporate Officer/Principal | 2005-09-30 |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology Develops antibody-based therapeutics | Director/Board Member | - |
Training of Frédéric Legros
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 7 |
|---|---|
Valneva SE
Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
NEOMA Business School
NEOMA Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology Develops antibody-based therapeutics | Health Technology |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
Cnrs Innovation SA
Cnrs Innovation SA Miscellaneous Commercial ServicesCommercial Services Provides scientific technology consulting services | Commercial Services |
ARTHEx Biotech SL
ARTHEx Biotech SL Miscellaneous Commercial ServicesCommercial Services Engages in development of antisense RNA treatments against genetic diseases | Commercial Services |
Anoat Therapeutics SAS
Anoat Therapeutics SAS BiotechnologyHealth Technology Develops novel therapies for cystic fibrosis | Health Technology |
- Stock Market
- Insiders
- Frédéric Legros
















